Submission Site for ISHLT 2024 Annual Meeting Abstracts Now
Accepting abstracts from researchers, clinicians, and junior faculty across all professional disciplines involved in advanced heart and lung disease and...
Source: globenewswire.com
Research Abstracts News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Research Abstracts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Research Abstracts Today - Breaking & Trending Today
Submit Your Best Science: ISHLT Accepting Abstracts for its 2023 Annual Meeting
/PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) has opened abstract submissions for its 43rd Annual Meeting & Scientific...
Source: prnewswire.com
Bristol Myers Squibb Presents Positive Data from Two Pivotal Phase 3 Psoriasis Studies Demonstrating Superiority of Deucravacitinib Compared to Placebo and Otezla®
Bristol Myers Squibb Presents Positive Data from Two Pivotal Phase 3 Psoriasis Studies Demonstrating Superiority of Deucravacitinib Compared to Placebo and Otezla® Significantly more patients treated with deucravacitinib achieved PASI 75 and sPGA 01 compared to patients treated with placebo and Otezla at Week 16, with an increased benefit versus Otezla at Week 24 and maintained through Week 52 Deucravacitinib was well tolerated with a low rate of discontinuation due to adverse events Deucravacitinib is a first-in-class, oral, selective tyrosine kinase 2 inhibitor with a unique … Significa...
Source: investingnews.com